🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease
#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens
🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease
#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens
📊 Data source: NHIS 2019-2023
🔎 Evaluated financial toxicity (related to medical care and medical condition) among those with rheumatic disease, cancer, both, or neither; and stratified by age (65 yrs)
#ACR25
📊 Data source: NHIS 2019-2023
🔎 Evaluated financial toxicity (related to medical care and medical condition) among those with rheumatic disease, cancer, both, or neither; and stratified by age (65 yrs)
#ACR25
Key take aways:
• HCQ should be standard therapy
• Use GC with precision
• Introduce immunosuppressive therapies early
• Use shared decision-making when considering treatment decisions
#ACR25
Key take aways:
• HCQ should be standard therapy
• Use GC with precision
• Introduce immunosuppressive therapies early
• Use shared decision-making when considering treatment decisions
#ACR25
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador
🔑HCQ= standard therapy
🔑GCs to control initial inflammation/flare; taper ASAP
🔑Early use of immunosuppressive therapies
🔑Shared decision making
#ACR25 #ACRambassador